Feed

26/10/2021
CMS ad­vised Vista Au­gen­prax­en & Klinik­en
Vista Klinik Hold­ing AG in Bin­nin­gen has ac­quired Au­gen­zen­trum Brugg AG in Brugg on 30 Ju­li 2021. Be­sides sev­er­al con­sulta­tion rooms the Au­gen­zen­trum Brugg has also an op­er­at­ing room for oph­thal­mic sur­gic­al pro­ced­ures such as catar­act and glauc­oma sur­gery, as well as new ret­ina op­er­a­tions. Vista will ex­pand the ex­ist­ing glauc­oma ser­vices and add ret­ina con­sulta­tions. In ad­di­tion to Dr. med. Milada Keller and Dr. Miri­am Adam­cova, Dr. med. Irak­lis Vas­t­ard­is will join the team in Brugg.Fur­ther­more, on 15 Septem­ber 2021 Vista Klinik Hold­ing AG has taken over Au­gen­k­linik-Seefeld AG in Zurich. In ad­di­tion to a vis­ion school, all oph­thal­mo­lo­gic­al treat­ments are offered in the prac­tice. Sur­ger­ies can be covered at the Vista eye clin­ics in the Zurich area. While Peter Trüb, MD, will re­tire at the end of 2021, Peter Schöne­born, MD, will con­tin­ue his work at the Au­gen­k­linik Seefeld.Fi­nally, on 28 Septem­ber 2021 Vista Klinik Hold­ing AG ac­quired a par­ti­cip­a­tion in PD Dr. Eis­en­mann Prax­is für Au­gen­heilkunde AG in Chur. The prac­tice on Bahnhof­strasse in Chur has two ex­am­in­a­tion rooms and a vis­ion school. The co­oper­a­tion is in­ten­ded to ex­pand the range of oph­thal­mo­lo­gic­al ser­vices and cre­ate a re­gion­al cen­ter for oph­thal­mo­logy in the Gris­ons cap­it­al. PD Dr. med. Di­eter Eis­en­mann will act as Head Phys­i­cian Oph­thal­mo­logy/Oph­thal­mic Sur­gery as well as Med­ic­al Dir­ect­or of the Chur re­gion.The ac­quis­i­tions and the par­ti­cip­a­tion serve to ex­pand the geo­graph­ic­al loc­a­tions and the ex­pert net­work of Vista Au­gen­prax­en & Klinik­en. Foun­ded over 30 years ago, Vista Au­gen­prax­en & Klinik­en is now a lead­ing centre of ex­cel­lence for oph­thal­mo­logy in Switzer­land. With 20 loc­a­tions in the Basel, Li­estal, Brugg, Zurich, Schwyz and Chur area, Vista has a broad net­work of eye clin­ics and eye prac­tices. At all loc­a­tions, spe­cial­ised oph­thal­mo­lo­gists of­fer all treat­ments and in­ter­ven­tions re­lat­ing to the eye. In this way, Vista guar­an­tees com­pre­hens­ive and lifelong care for its pa­tients. For­ward-look­ing re­search activ­it­ies and the con­tinu­ous train­ing of all em­ploy­ees en­sure qual­ity and sus­tain­ab­il­ity at all loc­a­tions.A team of CMS Switzer­land, led by part­ner Stefan Brunnsch­weiler, ad­vised Vista Au­gen­prax­en & Klinik­en on all leg­al mat­ters of the trans­ac­tion. CMS Switzer­land­Stefan Brunnsch­weiler, Part­ner, Cor­por­ate / M&AFran­ziska Ham­mer, Coun­sel, Cor­por­ate / M&ASamuel Fe­lix Gang, As­so­ci­ate, Cor­por­ate / M&A
26/10/2021
5G vis­ion video series
A video series on the de­ploy­ment of 5G across the world
25/10/2021
Fa­cing the fu­ture of in­ter­na­tion­al ar­bit­ra­tion
New pod­cast series ex­plor­ing the evolving chal­lenges and in­nov­a­tions of in­ter­na­tion­al ar­bit­ra­tion by the mem­bers of the CMS In­ter­na­tion­al Ar­bit­ra­tion Group
21/10/2021
The Lim­ited Qual­i­fied In­vestor Fund (L-QIF): a new flex­ible in­vest­ment...
The Lim­ited Qual­i­fied In­vestor Fund (L-QIF) is de­vised as a new fund vehicle un­der Swiss fund reg­u­la­tions. No ap­prov­al or au­thor­isa­tion by the Swiss Fin­an­cial Mar­ket Su­per­vis­ory Au­thor­ity (FINMA) will...
21/10/2021
In­ter­na­tion­al ar­bit­ra­tion law and rules in Switzer­land
Most ar­bit­ra­tions in Switzer­land are in­ter­na­tion­al. Only a small minor­ity of agree­ments between two Swiss com­pan­ies in­cludes an ar­bit­ra­tion clause. The two Swiss hubs for com­mer­cial ar­bit­ra­tion are Zurich...
2021
CMS - Where to find us
For a com­pact over­view of all CMS of­fices and con­tact de­tails, please down­load the bro­chure be­low. For more in­form­a­tion on our ser­vices, please refer to the coun­tries pan­el at the top of the page. 
12/10/2021
Leg­al guide for com­pany dir­ect­ors and CEOs in Switzer­land
Dir­ect­ors du­ties and re­spons­ib­il­it­ies 1. What form does the board of dir­ect­ors take? In Switzer­land, com­pan­ies have a single board of dir­ect­ors (“Ver­wal­tung­s­rat”). Many com­pan­ies how­ever use the...
12/10/2021
On­line gambling law and reg­u­la­tion in Switzer­land
Foot­notes With ef­fect from 1 Janu­ary 2019, Switzer­land’s new Fed­er­al Act on Money Games (“AMG”) entered in­to force. The AMG ap­plies to all kinds of on­line real money games, in­clud­ing vari­ations...
08/10/2021
The Ven­ture Cap­it­al Law Re­view: Switzer­land
In re­cent years, the Swiss start-up scene has de­veloped strongly and the in­ter­na­tion­al per­cep­tion of Switzer­land as a start-up and in­vest­ment loc­a­tion has sig­ni­fic­antly in­creased. While the num­ber of...
30/09/2021
CMS ad­vised the share­hold­ers of AL­PORA AG on the sale of a ma­jor­ity stake...
Zurich, Septem­ber 2021 | A team of CMS Switzer­land un­der the lead of Stefan Brunnsch­weiler provided com­pre­hens­ive ad­vice to the share­hold­ers of AL­PORA AG on all leg­al as­pects re­gard­ing the sale of a ma­jor­ity stake to Ger­man-based Ser­afin As­set Man­age­ment. Duff & Phelps, A Kroll Busi­ness, served as the ex­clus­ive fin­an­cial ad­visor to the share­hold­ers of AL­PORA AG in con­nec­tion with the trans­ac­tion. AL­PORA AG, which was foun­ded in 2013, is act­ive in the sale of in­nov­a­tion ana­lys­is-based in­vest­ment mod­els to as­set man­agers in Switzer­land, Ger­many and the UK. Based on these in­vest­ment mod­els, cli­ents set up equity funds that have his­tor­ic­ally been able to gen­er­ate a risk-ad­jus­ted ex­cess re­turn on equity in­vest­ments. The Ser­afin Group in­tends to enter a new seg­ment with Ser­afin As­set Man­age­ment and es­tab­lish a di­git­al as­set man­age­ment busi­ness. It is en­vis­aged to enter the mar­ket with ser­vices for third-party cus­tom­ers in the second quarter of 2022 after ob­tain­ing the BaFin li­cense. In ad­di­tion to de­vel­op­ing and selling its own in­vest­ment solu­tions, the aim is to grow by ac­quir­ing spe­cial­ized as­set man­agers. The ac­quis­i­tion of a ma­jor­ity stake in the Swiss-based AL­PORA AG is the first step in this dir­ec­tion. The parties have agreed not to dis­close the pur­chase price of the trans­ac­tion. Stefan Brunnsch­weiler, Lead, Man­aging Part­ner, Glob­al Co-Head of the CMS Cor­por­ate/M&A GroupSamuel Fe­lix Gang, As­so­ci­ate, Cor­por­ate/M&AFlori­an Jung, As­so­ci­ate, Cor­por­ate/M&APas­cal Stock­er, As­so­ci­ate, Cor­por­ate/M&AAndrea Relly, Seni­or As­so­ci­ate, Cor­por­ate/M&AM­ark Ca­gi­enard, Part­ner, Tax­Chris­ti­an Gers­bach, Part­ner, Em­ploy­ment­Dr Mat­thi­as Kuert, Seni­or As­so­ci­ate, Cap­it­al Mar­ket­sTarik Salkim, Train­ee, Cor­por­ate/M&A
30/09/2021
Swiss su­per­vis­ory au­thor­ity is­sues Guid­ance on fit and prop­er test for...
On 22 Septem­ber 2021, Switzer­land's fin­an­cial reg­u­lat­or FINMA pub­lished a prac­tic­al Guid­ance, which lays out its cri­ter­ia for con­duct­ing fit and prop­er tests when as­sess­ing can­did­ates un­der con­sid­er­a­tion...
30/09/2021
Busi­ness Hu­man Rights emer­ging as a new field of ar­bit­ra­tion?
In 2011, the Hu­man Rights Coun­cil of the UN Gen­er­al As­sembly pub­lished the "Guid­ing Prin­ciples on Busi­ness and Hu­man Rights". The gen­er­al pur­pose be­hind these prin­ciples is to en­hance stand­ards and prac­tices...